SUTRO BIOPHARMA INC. - COMMON STOCK

Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones

08 أغسطس 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference

03 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck

26 يوليو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs

12 يوليو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)

27 يونيو 2022 18:31:00 بحسب Nasdaq GlobeNewswire

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 يونيو 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

02 يونيو 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones

09 مايو 2022 15:30:00 بحسب Nasdaq GlobeNewswire